No Data
Express News | Tang Capital Management, LLC Reports 9.7% Stake in ESSA Pharma as of Nov 1- SEC Filing
ESSA Pharma(EPIX.US) 10% Shareholder Sells US$12.02 Million in Common Stock
$ESSA Pharma(EPIX.US)$ 10% Shareholder BIOTECH GROWTH N V sold 7.88 million shares of common stock on Nov 1, 2024 at an average price of $1.5253 for a total value of $12.02 million. This transaction
ESSA Pharma Slides As Insider Purchases Lose Another US$211k
ESSA Pharma Shares Are Trading Lower After Oppenheimer Downgraded the Stock From Outperform to Perform. Piper Sandler Downgraded Its Rating From Overweight to Neutral and Cut Its Price Target From $15 to $2.
Essa Pharma Price Target Cut to $2.00/Share From $15.00 by Piper Sandler
Essa Pharma Cut to Perform From Outperform by Oppenheimer
No Data
No Data